Product image of Forsteo (Teriparatide) supplied by GNH India

Forsteo

Active Ingredient:
Teriparatide
Origin:
EU

Forsteo (Teriparatide)

Forsteo (Teriparatide) is a subcutaneous medication used to treat osteoporosis. It helps improve bone density and reduce fracture risk. Learn more about its uses and effects.

Manufacturer / TM Owner

Eli Lilly Nederland B.V.

1
Pack/s
This product is added to your enquiry list

Request a Quote

Please fill out the form below and our team will get back to you shortly with pricing and further information.

A minimum order value applies. Our team will confirm the exact amount or quantity after reviewing your requirements.

Indications & Clinical Uses

  • Forsteo, containing the active ingredient Teriparatide, is primarily used for the treatment of osteoporosis in postmenopausal women and men at high risk for fracture. It works by stimulating bone formation, which can help increase bone mass and strength. People often ask, 'What is Forsteo used for?' and the answer is that it is designed to reduce the risk of fractures in individuals with severe osteoporosis who are at high risk for bone breaks.

Side Effects

  • Common effects of Forsteo may include injection site reactions such as redness, swelling, or pain. Some users might experience dizziness, nausea, or leg cramps. These effects are generally mild and temporary. It's important to monitor any persistent or severe reactions and consult a healthcare provider if necessary.

Precautions & Warnings

  • Forsteo should be used with caution in individuals with a history of bone cancer or metabolic bone diseases. It is not recommended for use in patients with Paget's disease of bone or hypercalcemia. Always follow the advice of a healthcare professional regarding the use of this medication.

Avoid Interactions

  • Forsteo may interact with other medications, including those that affect calcium levels or bone metabolism. It is important to inform your healthcare provider about all medications you are taking to avoid potential interactions. Alcohol and certain supplements may also affect the efficacy of Forsteo.

Frequently Asked Questions

Forsteo is used to treat osteoporosis by stimulating bone formation and increasing bone mass, reducing the risk of fractures.

Forsteo is administered via subcutaneous injection, typically once daily.

Common side effects include injection site reactions, dizziness, nausea, and leg cramps.

Forsteo may interact with other medications, so it's important to consult a healthcare provider before combining it with other treatments.

Individuals with a history of bone cancer, Paget's disease of bone, or hypercalcemia should avoid using Forsteo.

Published by

GNH India Pharmaceuticals Limited

Licensed pharmaceutical supplier

Last updated:

Disclaimer

At GNH India, we aim to provide information that is expert-reviewed, accurate, and reliable. However, all content on this platform is intended for general informational purposes only and does not constitute professional medical advice, diagnosis, or treatment. While efforts are made to maintain accuracy and currency, the information may contain errors, omissions, or may not reflect the latest developments. Always consult a qualified healthcare professional regarding any medical concerns.

All product names, brand names, trademarks and registered trademarks displayed on this website are the property of their respective owners. This website and its operator are not affiliated with, endorsed by, or authorized by any such trade mark owners unless expressly stated. Any reference to product names or trademarks is made solely for descriptive and informational purposes. No commercial relationship, sponsorship, approval, or association with any trademark owner should be inferred. Information provided herein does not constitute promotion, advertising, or an offer for sale of any medicinal product and is intended solely for general informational purposes.

All trademarks and brand names displayed on this website are used strictly in accordance with the provisions of the Trade Marks Act, 1999, specifically Sections 30 and 30(1) governing fair use. Trademark ownership has been accurately attributed under the "Manufacturer/ TM Owner" section in compliance with statutory requirements.

Related Products

Other formulations containing Teriparatide

A

A
A

A
A

A
A

A

Browse all products →

Ordering Process

Simple, Secure, and Seamless

Learn how our streamlined ordering process guarantees fast, compliant, and reliable access to essential medicines worldwide.

Quote request form

01

Submit Quote Request Form

Tell us what medications you need by filling out our simple form and uploading a valid document.

Price estimate review

02

We Review & Send Estimate

Our licensed pharmacists will verify your details and provide you with a detailed cost estimate.

Secure payment

03

Confirm & Make Payment

Discuss any queries, approve the estimate, and complete your payment.

Worldwide delivery

04

Get Delivered

Your medicines, safely packed and delivered to your door or nearest airport — hassle-free.

Regulatory recognitions

Quality You Can Trust

Our internationally recognized certifications underscore our commitment to safety, quality, and excellence.

SGS GSDP Certification

GSDP Compliant from SGS

URS ISO 9001

URS ISO 9001 Certification

FDA Maharashtra

Licensed by FDA Maharashtra

IEC License DGFT

IEC License issued by DGFT